MacroGenics
MGNX
#8586
Rank
NZ$0.34 B
Marketcap
NZ$5.39
Share price
5.86%
Change (1 day)
159.80%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.35 Billion

According to MacroGenics's latest financial reports the company's total liabilities are NZ$0.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.25 B11.97%
2023-12-31NZ$0.23 B5.72%
2022-12-31NZ$0.21 B55.77%
2021-12-31NZ$0.14 B21.91%
2020-12-31NZ$0.11 B-5.54%
2019-12-31NZ$0.12 B-8.64%
2018-12-31NZ$0.13 B26.6%
2017-12-31NZ$0.10 B71.26%
2016-12-31NZ$61.37 M-8.55%
2015-12-31NZ$67.11 M-0.03%
2014-12-31NZ$67.13 M17.71%
2013-12-31NZ$57.03 M-24.31%
2012-12-31NZ$75.34 M-26.64%
2011-12-31NZ$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$213.17 B 59,471.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$150.92 B 42,077.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$143.88 B 40,107.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$63.93 B 17,766.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$147.87 B 41,224.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$125.62 B 35,005.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.42 B 17.74%๐Ÿ‡บ๐Ÿ‡ธ USA